Unlikely to cause harm — often a labeling or packaging issue.
Cross Contamination With Other Product: Imipramine
| Brand name | AMITRIPTYLINE HYDROCHLORIDE |
| Generic name | AMITRIPTYLINE HYDROCHLORIDE |
| Active ingredient(s) | AMITRIPTYLINE HYDROCHLORIDE |
| Distributed by / for | Sandoz Incorporated |
| NDC | 0781-1487-01 |
| Full product label | Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540 |
| Recalling firm | Sandoz Incorporated |
| Distribution | Product was distributed throughout the United States |
| Quantity | 38,234 bottles |
| Recall initiated | 2017-06-16 |
| Report date | 2017-07-12 |
| Recall completed | 2019-01-14 |
| Recall number | D-0943-2017 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Broomfield CO United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗